Laura von Schantz

Laura von Schantz is a Chief Technology Officer with a background in biopharmaceutical development and manufacturing, specifically in antibody development and immuno-oncology. Laura has experience working at Alligator Bioscience AB, Lund University, and Dilafor AB in various roles such as Director, Senior Scientist, and Research Scientist. Laura has a PhD in Immunotechnology from Lund University and holds a Master of Business Administration (MBA) from Blekinge Institute of Technology. In addition, Laura has received additional education in Elements of AI and artificial intelligence.